As of 2025-03-15, the EV/EBITDA ratio of agilon health Inc (AGL) is -6.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 1,516.49 mil USD. AGL's TTM EBITDA according to its financial statements is -229.58 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.3x | 12.8x |
| Forward P/E multiples | 11.5x - 13.0x | 12.4x |
| Fair Price | (6.04) - (6.89) | (6.64) |
| Upside | -249.2% - -270.1% | -264.1% |
| Date | EV/EBITDA |
| 2025-03-12 | -6.41 |
| 2025-03-11 | -6.25 |
| 2025-03-10 | -5.74 |
| 2025-03-07 | -5.64 |
| 2025-03-06 | -5.67 |
| 2025-03-05 | -5.69 |
| 2025-03-04 | -5.03 |
| 2025-03-03 | -4.68 |
| 2025-02-28 | -4.94 |
| 2025-02-27 | -5.35 |
| 2025-02-26 | -5.37 |
| 2025-02-25 | -5.85 |
| 2025-02-24 | -5.87 |
| 2025-02-21 | -5.65 |
| 2025-02-20 | -5.83 |
| 2025-02-19 | -5.74 |
| 2025-02-18 | -5.51 |
| 2025-02-14 | -5.47 |
| 2025-02-13 | -5.58 |
| 2025-02-12 | -5.74 |
| 2025-02-11 | -5.49 |
| 2025-02-10 | -5.24 |
| 2025-02-07 | -5.31 |
| 2025-02-06 | -5.22 |
| 2025-02-05 | -5.62 |
| 2025-02-04 | -5.58 |
| 2025-02-03 | -5.42 |
| 2025-01-31 | -5.33 |
| 2025-01-30 | -5.78 |
| 2025-01-29 | -5.49 |
| 2025-01-28 | -5.64 |
| 2025-01-27 | -5.42 |
| 2025-01-24 | -5.82 |
| 2025-01-23 | -5.96 |
| 2025-01-22 | -5.71 |
| 2025-01-21 | -5.46 |
| 2025-01-17 | -4.88 |
| 2025-01-16 | -4.65 |
| 2025-01-15 | -4.40 |
| 2025-01-14 | -4.27 |
| 2025-01-13 | -4.50 |
| 2025-01-10 | -3.70 |
| 2025-01-08 | -3.27 |
| 2025-01-07 | -3.19 |
| 2025-01-06 | -3.03 |
| 2025-01-03 | -3.09 |
| 2025-01-02 | -2.78 |
| 2024-12-31 | -2.74 |
| 2024-12-30 | -2.76 |
| 2024-12-27 | -2.74 |